A crucial seminar addressing the role of cyclic adenosine monophosphate (cAMP) in sperm motility will take place at Weill Cornell Medicine on January 20, 2026. The event, led by Carla Ritagliati, Ph.D., an instructor in the Department of Pharmacology, aims to explore how targeting soluble adenylyl cyclase (sAC) could lead to innovative contraceptive methods.
The seminar is scheduled for 4:00 PM to 5:00 PM in the Anne Evans Estabrook Lecture Hall, located at 1300 York Avenue, New York, N.Y.. Drs. Jochen Buck and Lonny Levin will host the event, highlighting the significance of cAMP in regulating sperm movement and its implications for reproductive health.
Understanding sperm motility is vital for advancing contraceptive technologies. cAMP is a key signaling molecule that influences various cellular functions, including the movement of sperm. Dr. Ritagliati’s presentation will delve into the mechanisms by which sAC affects sperm motility, potentially opening pathways for new contraceptive approaches that are both effective and reversible.
Attendees will have the opportunity to engage with Dr. Ritagliati’s research, which builds on existing knowledge in reproductive biology and pharmacology. The seminar is expected to attract experts and students interested in the intersection of science and reproductive health.
This event represents a significant step in the ongoing dialogue surrounding contraception and fertility. By targeting specific molecular pathways, researchers like Dr. Ritagliati aim to develop safe and effective contraceptive options that could transform family planning practices.
For further details regarding the seminar, visit the official Weill Cornell Medicine events page.
